Literature DB >> 9366415

Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.

Y Hsing1, B S Hostager, G A Bishop.   

Abstract

CD40 signaling to B cells is important for generating an effective humoral immune response. CD40 ligation leads to B cell activation events such as proliferation, Ig secretion, isotype switching, and up-regulation of cell surface molecules, as well as the generation of memory B cells. Many of these events are dependent upon the ability of CD40 to activate the transcription factor NF-kappa B (NF-kappa B). To define the CD40 signaling components upstream of NF-kappa B activation and the functional consequences downstream of NF-kappa B activation, we examined mouse B cell transfectants expressing wild-type or mutant human CD40. Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation. A threonine residue at position 234, previously shown to be important for CD40 association with TNF receptor-associated factor 2 (TRAF2), TRAF3, and TRAF5, was not required for NF-kappa B activation. This suggests that in B cells, CD40-induced NF-kappa B activation can occur independently of TRAF2 and TRAF5 association. NF-kappa B activation was independent of the transmembrane domain of CD40, suggesting that it is independent of p23, a molecule that associates with CD40 in a region other than the cytoplasmic domain. Proteasome-dependent inhibitory kappa B alpha (I kappa B alpha) and I kappa B beta degradation occurred downstream of CD40 ligation and preceded CD40-mediated NF-kappa B nuclear translocation. CD40- or pervanadate-mediated I kappa B tyrosine phosphorylation was not detected. NF-kappa B activation correlated with the ability of CD40 to induce Ab secretion and the up-regulation of ICAM-1 and LFA-1. However, NF-kappa B activation was insufficient for CD40-mediated up-regulation of B7-1, Fas, and CD23.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.

Authors:  Cory Ahonen; Eric Manning; Loren D Erickson; Brian O'Connor; Evan F Lind; Steven S Pullen; Marilyn R Kehry; Randolph J Noelle
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

Review 3.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation.

Authors:  Hanna J Lee; Angela Lombardi; Mihaela Stefan; Cheuk Wun Li; William B Inabnet; Randall P Owen; Erlinda Concepcion; Yaron Tomer
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

5.  The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents.

Authors:  O Jirapongsananuruk; D Y Leung
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

6.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

7.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

8.  Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

9.  In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

Authors:  L Guedez; W G Stetler-Stevenson; L Wolff; J Wang; P Fukushima; A Mansoor; M Stetler-Stevenson
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

10.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.